
Ligand-based or structure-based virtual screening?
Virtual screening is a well-known approach in drug discovery projects to find new leads in virtual libraries of small molecules, but it
Virtual screening is a well-known approach in drug discovery projects to find new leads in virtual libraries of small molecules, but it
By Alessandro Deplano – Sep. 20, 2017 NOTE: THERE IS A NEW VERSION OF THIS SCRIPT. VISIT THIS PAGE TO DOWNLOAD IT.
Enric Herrero, Pharmacelera’s CTO, is giving a talk about conformation generation at the RDKit User Group Meeting, held in Berlin from Sept
Check out our new user interface for PharmScreen! Perform virtual screening campaigns with just a few clicks and take advantage of Pharmacelera’s
PharmScreen field-based alignment outperforms traditional solutions by taking into account relevant ligand characteristics related with ligand-receptor interaction.PharmScreen superior alignment allows finding better
Using scientific software can be frustrating and time-consuming if user experience has not been taken into account, resulting in less productive research.
Does the accuracy of quantum-mechanical (QM) descriptors at density functional theory (DFT) level justify its computational requirements for molecular superposition? In this
Pharmacelera is going to attend BIO International Convention this June in San Diego. Don’t miss the opportunity to meet us and know
The Center for the Development of Industrial Technology ranks Pharmacelera in the top 5% most innovative companies of 2016 and, as such,
This image shows a successful small-molecule alignment using a multi-reference strategy on a set of D2/D4 inhibitors. As it can be observed,
Pharmacelera has recently moved its offices to the Barcelona Tech City space (Pier 01) in the Barceloneta neighbourhood. Barcelona Tech City was
Pharmacelera has been selected as one of the finalists of the Startup Challenge 2016 program organized by the Pistoia Alliance! This is
Pharmacelera has attended BIOSPAIN 2016 in Bilbao. BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and
After receiving the Seal-Of-Excellence from the European Union SME Instrument program under the umbrella of the H2020 framework, Pharmacelera has been awarded
Pharmacelera’s CEO, Enric Gibert has been selected as member of the Industrial Advisory Committee (IAC) of PRACE. This membership is aligned with
Pharmacelera has been selected to participate in the Digital Enterprise show 2016. A selected group of the most innovative startups in the